Trial Profile
A Phase 2 Trial of Myocet, Cyclophosphamide +/- Trastuzumab Followed by Weekly Paclitaxel +/- Trastuzumab as Primary Systemic Therapy in Operable and Locally Advanced Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 May 2014
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Trastuzumab (Primary) ; Cyclophosphamide; Paclitaxel
- Indications Breast cancer
- Focus Therapeutic Use
- 07 May 2014 New trial record